Latest filings (excl ownership)
EFFECT
Notice of effectiveness
22 Sep 17
EFFECT
Notice of effectiveness
22 Sep 17
EFFECT
Notice of effectiveness
22 Sep 17
EFFECT
Notice of effectiveness
22 Sep 17
EFFECT
Notice of effectiveness
22 Sep 17
EFFECT
Notice of effectiveness
22 Sep 17
EFFECT
Notice of effectiveness
22 Sep 17
15-12B
Securities registration termination
31 Aug 17
25-NSE
Exchange delisting
31 Aug 17
8-K
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR
31 Aug 17
POS AM
Prospectus update (post-effective amendment)
31 Aug 17
POS AM
Prospectus update (post-effective amendment)
31 Aug 17
POS AM
Prospectus update (post-effective amendment)
31 Aug 17
POS AM
Prospectus update (post-effective amendment)
31 Aug 17
POS AM
Prospectus update (post-effective amendment)
31 Aug 17
POS AM
Prospectus update (post-effective amendment)
31 Aug 17
POS AM
Prospectus update (post-effective amendment)
31 Aug 17
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Aug 17
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Aug 17
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Aug 17
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Aug 17
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Aug 17
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Aug 17
8-K
Submission of Matters to a Vote of Security Holders
18 Aug 17
10-Q
2017 Q2
Quarterly report
9 Aug 17
DEFA14A
Additional proxy soliciting materials
4 Aug 17
DEFM14A
Proxy related to merger
14 Jul 17
8-K
Other Events
10 Jul 17
DEFA14A
Additional proxy soliciting materials
10 Jul 17
PREM14A
Preliminary proxy related to merger
3 Jul 17
8-K
AMRI Announces Early Termination of HSR Waiting Period for The Carlyle Group and GTCR’s Proposed Acquisition of AMRI
29 Jun 17
DEFA14A
Additional proxy soliciting materials
29 Jun 17
8-K
AMRI Signs Definitive Agreement To Be Acquired By The Carlyle Group and GTCR for $21.75 per share in cash
6 Jun 17
DEFA14A
Additional proxy soliciting materials
6 Jun 17
DEFA14A
Additional proxy soliciting materials
6 Jun 17
DEFA14A
Additional proxy soliciting materials
6 Jun 17
DEFA14A
Additional proxy soliciting materials
6 Jun 17
DEFA14A
Additional proxy soliciting materials
6 Jun 17
DEFA14A
Additional proxy soliciting materials
6 Jun 17
8-K
Submission of Matters to a Vote of Security Holders
1 Jun 17
Latest ownership filings
SC 13G/A
Albany Molecular Research Inc
14 Feb 18
SC 13G/A
Albany Molecular Research Inc
13 Feb 18
4
MILTON BOYER
5 Sep 17
4
KENNETH PAUL HAGEN
5 Sep 17
4
Steven R Hagen
5 Sep 17
4
LORI M. HENDERSON
5 Sep 17
4
ANTHONY J MADDALUNA
5 Sep 17
4
KEVIN OCONNOR
5 Sep 17
4
William S Marth
5 Sep 17
4
AMBRA THOMAS E D
5 Sep 17
4
FERNANDO NAPOLITANO
5 Sep 17
4
George Svokos
5 Sep 17
4
Fuentes Luis Gerardo Gutierrez
5 Sep 17
4
Felicia I Ladin
5 Sep 17
4
CHRISTOPHER M. CONWAY
5 Sep 17
4
David H Deming
5 Sep 17
4
MARGALIT FINE
5 Sep 17
SC 13D/A
Albany Molecular Research Inc
5 Sep 17
SC 13D/A
Albany Molecular Research Inc
5 Sep 17
SC 13D/A
Albany Molecular Research Inc
5 Sep 17
SC 13D/A
Albany Molecular Research Inc
5 Sep 17
SC 13D/A
Albany Molecular Research Inc
5 Sep 17
4
MARGALIT FINE
18 Jul 17
4
William S Marth
6 Jul 17
4
MILTON BOYER
6 Jul 17
4
George Svokos
6 Jul 17
4
MILTON BOYER
5 Jul 17
4
KEVIN OCONNOR
26 May 17
4
ARTHUR J ROTH
26 May 17
4
UNA S RYAN
11 May 17
4
Felicia I Ladin
6 Mar 17
4
LORI M. HENDERSON
6 Mar 17
4
CHRISTOPHER M. CONWAY
6 Mar 17
4
MILTON BOYER
6 Mar 17
4
Steven R Hagen
6 Mar 17
4
George Svokos
6 Mar 17
4
Felicia I Ladin
21 Feb 17
SC 13G/A
Albany Molecular Research Inc
14 Feb 17
SC 13G/A
Albany Molecular Research Inc
14 Feb 17
SC 13G/A
Albany Molecular Research Inc
14 Feb 17